American Liver Foundation Joins 2026 TCS New York City Marathon

The American Liver Foundation (ALF) will participate in the 2026 TCS New York City Marathon charity program, scheduled for November 1. Runners representing the foundation will compete to highlight the prevalence of liver diseases and support ongoing advocacy efforts.

Participation in the New York City Marathon offers the foundation a platform to reach a large, international audience. By leveraging the scale of the event, the ALF aims to increase public understanding of liver health, preventative measures, and the necessity of early screening.

The annual marathon remains one of the largest philanthropic sporting events in the United States. Funds generated by team participants are intended to support the foundation’s patient resources and broader public health initiatives.